subject area of
- A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575) Academic Article
- A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors Academic Article
- Differential response of primitive human CD34− and CD34+ hematopoietic cells to the Notch ligand Jagged-1 Academic Article
- Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors Academic Article
- Lunatic Fringe Deficiency Cooperates with the Met/Caveolin Gene Amplicon to Induce Basal-like Breast Cancer Academic Article
- The Notch Ligand Jagged-1 Represents a Novel Growth Factor of Human Hematopoietic Stem Cells Academic Article